AI Company’s Acquisition of Genetic Testing Firm Sparks Landmark Privacy Lawsuit – What Employers and MedTech Should Know
Tempus AI is facing a class action lawsuit for allegedly sharing health data obtained during an acquisition with biotech and pharmaceutical companies.
A recent Illinois federal class action lawsuit alleges an AI healthcare company obtained health data during a corporate acquisition and shared that data with biotech and pharmaceutical companies in violation of key privacy laws. MedTech companies and their business customers should pay attention. The April 15 lawsuit targets Tempus AI, a Chicago-based healthcare technology company, and stems from its February 2025 acquisition of a genetic testing firm with a database of more than one million... By: Fisher Phillips